The AI model analyzes three biomarkers from routine breast cancer hematoxylin and eosin-stained slides to predict breast cancer status. The tool helps physicians and researchers better understand the links between biological factors for treatment and the tumor, an Aug. 11 news release on the study said.
Treatment plans for breast cancer rely on identifying biomarkers. The algorithm interprets the slides and predicts biomarkers to help physicians determine treatment plans quicker.
The model will eventually be used to help physicians determine a tumor’s histology and microscopic structure.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
